SEC Form 4 · accession 0000792977-18-000025
AMAG PHARMACEUTICALS INC. · AMAG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William K Heiden
Officer — President & CEO · Director
Period of report
Jun 4, 2018
Accepted (ET)
Jun 5, 2018 · 7:21 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000792977
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 4, 2018 | S | 20,000 | $25.00 | D | 333,015 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported transaction on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2017.